Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
ALT
CBIO
Add up to 3 more stocks
ALT
Altimmune, Inc.
+0.19%
$2.67+0.00Delayed quote: Oct 6, 2026, 2:10 PM EDT
Market Cap
$520.22M
52W Range
$2.56 - $6.44
CBIO
Crescent Biopharma, Inc.
-1.61%
$13.71-0.22Delayed quote: Oct 6, 2026, 2:10 PM EDT
Market Cap
$509.43M
52W Range
$8.72 - $27.41
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 1.10 | 3.20 |
| P/S Ratio | 16781.22 | 42.87 |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 100.0% | 100.0% |
| Operating Margin | -230461.0% | -1407.5% |
| Net Margin | -296000.0% | -1371.5% |
| ROE | -19.4% | -99.8% |
| ROA | -17.4% | -89.2% |
| ROIC | -19.5% | -102.6% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 26.78 | 9.66 |
| Quick Ratio | 26.78 | 9.66 |
| Debt/Equity | 0.08 | 0.01 |
| Interest Coverage | -57.76 | -69.85 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.